Microanalysis of catecholamines in human plasma by high-performance liquid chromatography with amperometric detection as compared with a radioenzymatic method

A high-performance liquid chromatographic procedure is described for the quantitative determination of epinephrine, norepinephrine, and dopamine in human plasma. The method, which is based on adsorption of the catecholamines to alumina and, after liberation, separation on a microparticulate bonded strong cation-exchange resin and amperometric detection, has been optimized to give complete baseline separation of the substances of interest. Dihydroxybenzylamine, a nonendogenous catecholamine, is used as the internal standard. The detection limit is about 0.1 pmol for dopamine. Analysis of data obtained for norepinephrine and epinephrine from a total of 59 plasma samples showed a good correlation to the corresponding values obtained with a radioenzymatic method. Some results from normal and pathological conditions are compared.     

Thin-layer chromatographic separation of acetylcholine,epinephrine, and serotonin from each other

A thin-layer Chromatographic procedure is reported for the separation of acetylcholine, epinephrine, and serotonin from each other. The method involves the use of cellulose coated plates and n-butanol-ethanol-acetic acid-water (8:2:1:3) as developing solvent. Norepinephrine and serotonin interfere with each other.     

A semi-automated method for fluorimetric determination of epinephrine and norepinephrine, without mutual interference, in single brain samples

A method is described for the separation and automated fluorimetric determination of epinephrine and norepinephrine in brain tissue extracts without mutual interference. The catecholamines are isolated and purified by extraction from activated alumina. Oxidation and rearrangement to their fluorescent lutines is carried out on two separate AutoAnalyzer manifolds and fluorescence is read in an Aminco-Bowman spectrophotofluorimeter. The interference by one amine with the determination of the other is less than 1% for determination of epinephrine in the presence of an equimolar concentration of norepinephrine, and, conversely, less than 4% for determination of norepinephrine. This eliminates the need for solution of simultaneous equations, the results of which are often misleading when the ratio of one amine to the other in brain exceeds 10:1. This method can be useful for rapid screening of psychoactive compounds affecting central and peripheral adrenergic stores.     

Fully automated high-performance liquid chromatographic assay for the analysis of free catecholamines in urine

A totally automated and reliable high-performance liquid chromatographic method is described for the routine determination of free catecholamines (norepinephrine, epinephrine and dopamine) in urine. The catecholamines were isolated from urine samples using small alumina columns. A standard automated method for pH adjustment of urine before the extraction step has been developed. The extraction was performed on an ASPEC (Automatic Sample Preparation with Extraction Columns, Gilson). The eluate was collected in a separate tube and then automatically injected into the chromatographic column. The catecholamines were separated by reversed-phase ion-pair liquid chromatography and quantified by fluorescence detection. No manual intervention was required during the extraction and separation procedure. One sample may be run every 15 min, ca. 96 samples in 24 h. Analytical recoveries for all three catecholamines are 63-87%, and the detection limits are 0.01, 0.01, and 0.03 microM for norepinephrine, epinephrine and dopamine, respectively, which is highly satisfactory for urine. Day-to-day coefficients of variation were less than 10%.     

An improved approach for the determination of plasma-free catecholamines by HPLC-ED: Application to normal and hypertensive patients

Summary A dual-step procedure for the rapid, quantitative isolation of free catecholamines (norepinephrine, epinephrine and dopamine) from plasma, using a little column of CM-Sephadex and alumina adsorption, is described. Sensitive high performance liquid chromatography is also discussed, employing an amperometric detector for the quantitative determination. The recovery of the three catecholamines, and of N-methyldopamine used as the internal standard, was about 70–80%; the detection limits were 2pg for norepinephrine, 3pg for epinephrine and 3pg for dopamine. The combination of the rather specific and easy to handle two-step sample clean-up procedure, the high resolving power of the chromatography and the high sensitivity of electrochemical detection provided a simple method for the determination of free catecholamines in plasma samples of normal and essential hypertensive subjects under different conditions (supine position for 45 min, standing for 5 and 10 min). It was found that a significant increase in epinephrine levels (P<0.01) occurred in hypertensive patients under the three conditions studied.     

Sensitive Analysis of 5-(4,6-Dichloro-s-triazin-2-ylamino)fluorescein-Labeled Catecholamines by Mixed MEKC–LIF

Mixed micellar electrokinetic chromatography with laser-induced fluorescence detection has been used for analysis of the catecholamines norepinephrine, epinephrine, and dopamine. The fluorescent reagent 5-(4,6-dichloro-s-triazin-2-ylamino)fluorescein was used to label the three compounds. The reaction rate increased with increasing alcohol concentration in the derivatization buffer. Under the optimum conditions the derivatization reaction was complete within 10 min. The separation was performed with 40 mM sodium cholate, 30 mM sodium dodecyl sulfate, 30 mM sodium borate (pH 9.6), and acetonitrile 8.0% (v/v) as running buffer. The applied potential was 25 kV and the capillary temperature was 25 °C. The detection limits for norepinephrine, epinephrine, and dopamine were 3.3, 0.25, and 1.26 nM. The method was successfully applied to monitoring of these catecholamines in human urine. Recovery of the three analytes ranged from 93.2 to 105.8%.     

Ion pairing high-performance liquid chromatography of catecholamines

Catecholamine standards have been separated by ion pairing reversed-phase high-performance liquid chromatography (HPLC). A trace substance was separable from four standards when low concentrations of methanol were used in the elution buffer. This method has allowed separation of an unknown uterine catecholamine, partially purified on a boronate affinity gel column, from the standards: norepinephrine, epinephrine, normetanephrine and metanephrine.     

High performance liquid chromatography coupled to an optical fiber detector coated with laccase for screening catecholamines in plasma and urine

An analytical method based on separation by high performance liquid chromatography (HPLC) and detection by optical fiber (OF) coated with an enzyme (laccase), has been developed for separation and quantification of catecholamines, namely epinephrine, dopamine and norepinephrine. The application of OF as a detector in this analytical system relies on the variation of the reflected optical power detected when the catecholamines eluted from the HPLC column act as the substrate of the laccase immobilized on a tip of a single-mode OF. The developed method shows a high linearity in a range between 5 and 125 pg/mL and detection limits of 3.5, 2.9 and 3.3 pg/mL for epinephrine, dopamine and norepinephrine, respectively. The analytical performance of the proposed method was compared with a classical analytical method, namely high performance liquid chromatography-electrochemical detector (HPLC-ED) regarding catecholamines detection, showing great analytical advantages such as low cost of equipment. Additionally, the proposed method was applied to catecholamines determination in actual samples of plasma and human urine.     

Estimation of plasma catecholamines by high-performance liquid chromatography with electrochemical detection in patients with subarachnoid haemorrhage

Plasma catecholamine levels were determined by high-performance liquid chromatography with electrochemical detection following alumina extraction. Mean individual recoveries of 50.5, 49.9 and 48% were obtained for norepinephrine, epinephrine and dopamine, respectively, and the limits of detection for each catecholamine were 0.15, 0.34 and 0.6 pmol/ml. Total analysis time for each plasma sample was approximately 1 h. Catecholamine levels were measured in plasma from control subjects and the ranges obtained were: norepinephrine, 0.33-5.98 pmol/ml; epinephrine, 0-4.77 pmol/ml; dopamine, 0-0.8 pmol/ml. When patients with subarachnoid haemorrhage were investigated, the ranges were found to be: norepinephrine, 0.23-7.27 pmol/ml; epinephrine, 0-4.91 pmol/ml; dopamine, 0-0.23 pmol/ml.     

Poly (acrylic acid) microchannel modification for the enhanced resolution of catecholamines microchip electrophoresis with electrochemical detection

A new modification of glass electrophoresis microchips based on poly (acrylic) acid immobilization has been performed. It is based on the reaction of PAA with an amine functionalized surface, obtained through the bifunctional reagent 3-aminopropyl triethoxysilane. Parameters affecting all the three steps involved: surface activation, silanization and polymer immobilization were optimized employing soda-lime glass plates. Characterization by SEM and XPS was carried out. Application of the modified microchips to the separation of a model system: dopamine (D), epinephrine (E) and norepinephrine (NE), that on the other hand are of high clinical relevance was performed employing amperometric detection. Modification is necessary for obtaining partial resolution of all the three analytes in a microchip with an effective separation length of 30 mm. Situation changes from no resolution (Rs) at all (only one peak was achieved for the mixture) to a partial resolution (Rs D–NE and Rs NE–E are 0.25 and 0.24 respectively). Microchips with 60 mm of separation channel were also modified, implying this procedure a resolution enhancement (Rs of 0.49 and 0.28 for D–NE and NE–E respectively), even when methanol is employed as organic modifier (Rs values of 0.70 (D–NE) and 0.66 (NE–E) for a 3% MeOH).     

Selective solid-phase extraction of catecholamines by the chemically modified polymeric adsorbents with crown ether

A simple and selective one-step solid-phase extraction procedure using chemically modified polymer resin (Amberlite XAD-4) with crown ether was investigated for the measurement of urinary catecholamines. After loading the urine samples (adjusted to pH 4) on the synthesized adsorbent cartridge, the column was washed with methanol followed by water and then the adsorbed catecholamines were eluted by 1.0 mL of 6.0 M acetic acid. The effectiveness of sample clean-up method was demonstrated by reversed-phase ion-pair high-performance liquid chromatography with electrochemical detection. Under optimal condition, the recoveries of epinephrine, norepinephrine, and dopamine from spiked urine sample were >86% for all catecholamines. The detection limits (n=5) for epinephrine, norepinephrine, and dopamine were 37, 52, and 46 nmol/L, respectively.     

Simultaneous determination of epinephrine and norepinephrine in human blood plasma and urine samples using nanotubes modified edge plane pyrolytic graphite electrode

The simultaneous determination of catecholamines - epinephrine and norepinephrine by square wave voltammetry (SWV) at physiological pH 7.2 is reported using multi-walled carbon nanotubes modified edge plane pyrolytic graphite electrode (MWNT/EPPGE). A broad bump at ∼250 mV is appeared for the oxidation of epinephrine (EP) and norepinephrine (NE) at bare EPPGE whereas at MWNT/EPPGE two well-separated peaks at ∼150 and ∼215 mV are appeared for the oxidation of EP and NE, respectively. The oxidation peak current of both the neurotransmitters also increased significantly along with the negative shift of peak potentials using MWNT/EPPGE. The oxidation of both compounds occurred in a pH dependent, 2e and 2H⁺ process and the electrode reaction followed diffusion controlled pathway. Linear calibration curves were obtained for epinephrine and norepinephrine in the range 0.5-100 nM with limits of detection 0.15 × 10⁻⁹ and 0.90 × 10⁻¹⁰ M, respectively. The developed protocol is implemented for the simultaneous determination of epinephrine and norepinephrine in blood plasma and urine samples of smokers as well as in athletes.     

Determination of highly polar catecholamine with liquid chromatography–tandem mass spectrometry using weak cation-exchange stationary phase to increase retention time

This paper reports method development and validation work to determine highly polar bases, catecholamine compounds, using weak cation-exchange liquid chromatography of low ionic strength mobile phase with electrospray tandem mass spectrometry. Catecholamine compounds, such as epinephrine and norepinephrine, well-known biomarkers to diagnose hypertension disease, spiked in saline solutions are purified with solid phase extraction (SPE) using alumina powders. The extracts are loaded into a weak cation-exchange liquid chromatographic column via an injection loop and analyzed with electrospray-mass spectrometer. The de-salted extracts contain only small amounts of electrolytes to avoid saturating weak cation-exchange sites in the stationary phase with sodium ions. Using carefully selected mobile-phase solvents with optimized compositions (acetonitrile and water 10:90 v/v) and with dilute acid additives (acetic acid 0.1% v/v), we are able to elute catecholamine at sufficient retention times to avoid co-elution of saline matrix residues while maintaining adequate electrospray ionization efficiency of these compounds. Using epinephrine and norepinephrine standards, these methods are validated at the range of 5 to 500 ng mL^− 1. The measurement accuracy and precision of using epinephrine standards are within 12% and 5.3% respectively, whereas the accuracy and precision are within 6.0% and 4.2% respectively using epinephrine standards.The detection limits of epinephrine and norepinephrine are 0.10 ng mL^− 1 and 0.45 ng mL^− 1 respectively. The recovery percentages of our solid phase extraction methods using alumina powders are higher than 74%. When the validated calibration curves are used to determine epinephrine and norepinephrine in rat blood dialysates, the determination errors of accuracy and precision are both within 4%, while the determination errors are within 3% in rat blood plasma samples.     

Quantitative determination of epinephrine and norepinephrine in the picogram range by flame ionization gas-liquid chromatography.

A gas-liquid chromatographic method has been developed using the hydrogen flame detector to determine epinephrine (E) and norepinephrine (NE) in blood plasma, red blood cells, serum, and urine. The chromatographic method presents several advantages over other existing techniques. The derivatives enable separation of E and NE and are stable at room temperature with no signs of decomposition. The detection limit for the catecholamines with the hydrogen detector was approximately 0.1 pg. The catecholamines can be determined simultaneously from the same gas-liquid chromatogram. Purification of the catecholamines using the conventional procedure of chromatographing on alumina has been eliminated. With this gas chromatographic method, no by-products are formed that interfere with E and NE determinations. Dopamine, which constitutes the major source of interference in the commonly used fluorometric methods, does not interfere with the E and NE determinations. Norepinephrine and epinephrine values for several physiological fluids are given with the analysis expanded to include red blood cells, the contents of which have not been previously reported.     

Optical fiber biosensor coupled to chromatographic separation for screening of dopamine, norepinephrine and epinephrine in human urine and plasma

An optical fiber biosensor has been developed for the determination of catecholamines (dopamine, norepinephrine and epinephrine) based on the recognition capacity of the enzyme laccase. In this study, a glass tube constituted by a fused silica fiber coated with a film of polystyrene/divinylbenzene resin (PS/DVB) was used for catecholamines separation. Firstly, the analyzer was tested for calibration and its analytical performance for catecholamines detection was compared with a classical analytical method, namely high performance liquid chromatography-electrochemical detector (HPLC-ED). The developed analytical device shows a high potential for catecholamines quantification with a detection limit of 2.1, 2.6 and 3.4 pg mL⁻¹ for dopamine, norepinephrine and epinephrine, respectively. The analytical sensitivity, inferred from the slope of the calibration curves established for a range of concentrations between 5 and 125 pg mL⁻¹, was found to be 0.344, 0.252 and 0.140 dB/pg mL⁻¹ for dopamine, norepinephrine and epinephrine, respectively. Furthermore, catecholamines speciation with the PS/DVB fiber was completely achieved in 3 min. The analytical performance of the reported sensor was also evaluated and found adequate for catecholamines determination in human urine and plasma samples.     

Routine determination of urinary free catecholamines by high-performance liquid chromatography with electrochemical detection

A simple and reliable high-performance liquid chromatographic method is described for the routine determination of the free catecholamines (norepinephrine, epinephrine and dopamine) in urine. The catecholamines are isolated from urine samples using small affinity chromatography columns prepacked with immobilised m-aminophenylboronic acid, separated by ion-pair reversed-phase liquid chromatography and quantified by electrochemical detection. Total analysis, including sample preparation time, is achieved in less than 30 min with analytical recoveries of 92-96% for all three catecholamines. Long-term stability and reproducibility of the liquid chromatographic system is attained by selection of optimised conditions for chromatographic separation with a formate mobile phase and produces detection limits of 1.4, 1.8 and 2.2 nmol/l for norepinephrine, epinephrine and dopamine, respectively, in urine samples and day-to-day coefficients of variation of less than 6%. Furthermore, the affinity isolation gels can be reused a minimum of ten times providing a rapid and cost-effective means of sample preparation.     

Determination of 13 Catecholamines,Indoleamines, Metabolites and Precursors in Less Than 20 Minutes During a Single HPLC Run

Abstract

Thirteen catecholamines and indoleamines are rapidly separated during a single HPLC run. They include epinephrine, norepinephrine, dopamine, serotonin, the major metabolites of these compounds and their immediate precursors. The technique was developed in order to analyze several biogenic amines in brain tissues simultaneously but the methodology has universal application. The separation is based on a fine balance between organic solvent, ion pairing reagent, buffers, pH, choice of column and flow rate.     

Is There a Novel Biosynthetic Pathway in Mice That Converts Alcohol to Dopamine,Norepinephrine and Epinephrine?

Previous studies in animals and humans have shown multiple types of interaction between alcohol (ethanol) intake and the catecholamine signaling molecules: dopamine, norepinephrine and epinephrine. This literature suggests that the administration of alcohol to rodents affects the central and peripheral (blood plasma) levels of these catecholamines. Two prior publications (Fitzgerald 2012, 2020) put forth the hypothesis that there may be a currently unidentified biosynthetic pathway, in a range of organisms, that actually converts alcohol to dopamine, norepinephrine and epinephrine. This publication describes the details for how to test this hypothesis in mice. Mice can be systemically injected with an intoxicating dose of commercially available stable isotope-labeled ethanol (ethanol-1-¹³C), and blood plasma samples and brains can be collected approximately two to 24 h post-injection. Liquid chromatography-mass spectrometry analysis can then be used to test whether some of the labeled ethanol molecules have been incorporated into new dopamine, norepinephrine, and epinephrine molecules, in plasma and brain samples. If confirmed, this hypothesis may have broadly reaching implications both for basic neuroscience and our understanding of alcohol abuse and alcoholism.     

Double stable isotope ultra performance liquid chromatographic-tandem mass spectrometric quantification of tissue content and activity of phenylethanolamine N-methyltransferase, the crucial enzyme responsible for synthesis of epinephrine

Here, we describe a novel method utilizing double stable isotope ultra performance liquid chromatography-tandem mass spectrometry to measure tissue contents and activity of phenylethanolamine N-methyltransferase (PNMT), the enzyme responsible for synthesis of the stress hormone, epinephrine. The method is based on measurement of deuterium-labeled epinephrine produced from the reaction of norepinephrine with deuterium-labeled S-adenosyl-l-methionine as the methyl donor. In addition to enzyme activity, the method allows for determination of tissue contents of PNMT using human recombinant enzyme for calibration. The calibration curve for epinephrine was linear over the range of 0.1 to 5,000 pM, with 0.5 pM epinephrine representing the lower limit of quantification. The calibration curve relating PNMT to production of deuterium-labeled epinephrine was also linear from 0.01 to 100 ng PNMT. Intra- and inter-assay coefficients of variation were respectively 12.8 % (n?=?10) and 10.9 to 13.6 % (n?=?10). We established utility of the method by showing induction of the enzyme by dexamethasone in mouse pheochromocytoma cells and strong relationships to PNMT gene expression and tissue epinephrine levels in human pheochromocytomas. Development of this assay provides new possibilities for investigations focusing on regulation of PNMT, the crucial final enzyme responsible for synthesis of epinephrine, the primary fight-or-flight stress hormone.

Determination of highly polar catecholamine with liquid chromatography–tandem mass spectrometry using weak cation-exchange stationary phase to increase retention time

This paper reports method development and validation work to determine highly polar bases, catecholamine compounds, using weak cation-exchange liquid chromatography of low ionic strength mobile phase with electrospray tandem mass spectrometry. Catecholamine compounds, such as epinephrine and norepinephrine, well-known biomarkers to diagnose hypertension disease, spiked in saline solutions are purified with solid phase extraction (SPE) using alumina powders. The extracts are loaded into a weak cation-exchange liquid chromatographic column via an injection loop and analyzed with electrospray-mass spectrometer. The de-salted extracts contain only small amounts of electrolytes to avoid saturating weak cation-exchange sites in the stationary phase with sodium ions. Using carefully selected mobile-phase solvents with optimized compositions (acetonitrile and water 10:90 v/v) and with dilute acid additives (acetic acid 0.1% v/v), we are able to elute catecholamine at sufficient retention times to avoid co-elution of saline matrix residues while maintaining adequate electrospray ionization efficiency of these compounds. Using epinephrine and norepinephrine standards, these methods are validated at the range of 5 to 500 ng mL^− 1. The measurement accuracy and precision of using epinephrine standards are within 12% and 5.3% respectively, whereas the accuracy and precision are within 6.0% and 4.2% respectively using epinephrine standards.The detection limits of epinephrine and norepinephrine are 0.10 ng mL^− 1 and 0.45 ng mL^− 1 respectively. The recovery percentages of our solid phase extraction methods using alumina powders are higher than 74%. When the validated calibration curves are used to determine epinephrine and norepinephrine in rat blood dialysates, the determination errors of accuracy and precision are both within 4%, while the determination errors are within 3% in rat blood plasma samples.